Table 3 3-year follow-up results of sexual function in two groups.
12 months | 24 months | 36 months | |||||||
---|---|---|---|---|---|---|---|---|---|
PVP (n = 60) | PKRP (n = 60) | P value | PVP (n = 60) | PKRP (n = 60) | P value | PVP (n = 60) | PKRP (n = 60) | P value | |
IIEF-5 | 9.18 ± 1.93 | 9.30 ± 2.18 | 0.757 | 9.63 ± 1.96 | 9.78 ± 2.26 | 0.698 | 9.63 ± 2.18 | 9.68 ± 2.47 | 0.907 |
DOE (%) | 44 (73.33) | 47 (78.33) | 0.522 | 38 (63.33) | 42 (70.00) | 0.439 | 35 (58.33) | 35 (58.33) | 1.000 |
RE (%) | 43 (71.67) | 44 (73.33) | 0.838 | 40 (66.67) | 39 (65.00) | 0.847 | 37 (61.67) | 37 (61.67) | 1.000 |
MSHQ-EjD | 10.38 ± 5.67 | 8.93 ± 5.54 | 0.159 | 10.38 ± 5.69 | 8.85 ± 5.69 | 0.142 | 10.38 ± 5.81 | 8.75 ± 5.71 | 0.123 |
MSHQ | 43.15 ± 18.47 | 40.20 ± 16.66 | 0.360 | 42.70 ± 18.42 | 39.78 ± 16.74 | 0.366 | 42.70 ± 18.61 | 39.68 ± 16.75 | 0.352 |